Literature DB >> 6423641

Three molecular weight forms of natural human interferon-gamma revealed by immunoprecipitation with monoclonal antibody.

H C Kelker, J Le, B Y Rubin, Y K Yip, C Nagler, J Vilcek.   

Abstract

Immune interferon (IFN-gamma), endogenously labeled with [35S]methionine, was produced in human peripheral blood lymphocyte cultures stimulated with 12-O-tetradecanoylphorbol-13-acetate and phytohemagglutinin. 35S-IFN-gamma, immunoprecipitated from the crude culture fluid with a monoclonal antibody, was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis into three monomeric forms with molecular weights of 25,000, 20,000, and 15,500, which we designate IFN-gamma I, II, and III, respectively. IFN-gamma I was the most, and IFN-gamma III the least, abundant in both immunoprecipitated 35S-IFN-gamma and chromatographically purified IFN-gamma preparations. Changes in the molecular size of the monomeric forms after glycosidase treatment suggested that IFN-gamma I contains more carbohydrate than IFN-gamma II, and that IFN-gamma III may not be glycosylated at all. Hence, the differences in the carbohydrate contents are likely to be the major cause of the molecular size heterogeneity of IFN-gamma I, II, and III.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423641

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Evaluation of antigen-specific T-cell responses with a miniaturized and automated method.

Authors:  Giuseppina Li Pira; Federico Ivaldi; Chiara Dentone; Elda Righi; Valerio Del Bono; Claudio Viscoli; Gerrit Koopman; Fabrizio Manca
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

2.  Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset.

Authors:  H Nakajima; Y Izumi; S Sugihara; Y Satoh; S Isumi; T Gotoh; H Fujiwara; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  N-glycosylation of human interferon-gamma: glycans at Asn-25 are critical for protease resistance.

Authors:  T Sareneva; J Pirhonen; K Cantell; I Julkunen
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

Review 4.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

5.  Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy.

Authors:  Ryan Chang; Gaetano Faleo; Holger A Russ; Audrey V Parent; Susanna K Elledge; Daniel A Bernards; Jessica L Allen; Karina Villanueva; Matthias Hebrok; Qizhi Tang; Tejal A Desai
Journal:  ACS Nano       Date:  2017-08-07       Impact factor: 15.881

Review 6.  Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.

Authors:  Flávia Castro; Ana Patrícia Cardoso; Raquel Madeira Gonçalves; Karine Serre; Maria José Oliveira
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

7.  Analysis of the frequency of single nucleotide polymorphisms in cytokine genes in patients with New Onset Diabetes After Transplant.

Authors:  Mohamed Jahromi; Torki Al-Otaibi; Osama Ashry Gheith; Nashwa Farouk Othman; Tarek Mahmoud; Parasad Nair; Medhat A-Halim; Parul Aggarwal; Grace Messenger; Philip Chu; Sacha A De Serres; Jamil R Azzi
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

Review 8.  Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma.

Authors:  Fransien van Dijk; Peter Olinga; Klaas Poelstra; Leonie Beljaars
Journal:  Front Med (Lausanne)       Date:  2015-10-05

9.  Silicon nanopore membrane (SNM) for islet encapsulation and immunoisolation under convective transport.

Authors:  Shang Song; Gaetano Faleo; Raymond Yeung; Rishi Kant; Andrew M Posselt; Tejal A Desai; Qizhi Tang; Shuvo Roy
Journal:  Sci Rep       Date:  2016-03-24       Impact factor: 4.379

10.  Natural human interferon-gamma derived from lipopolysaccharide-stimulated human myelomonocytic HBL-38 cells.

Authors:  S Ando; T Ohta; T Tanimoto; O Sano; H Yamauchi; O Andoh; K Torigoe; M Kurimoto
Journal:  Jpn J Cancer Res       Date:  1988-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.